Synergistic expression of angiotensin-converting enzyme (ACE) and ACE2 in human renal tissue and confounding effects of hypertension on the ACE to ACE2 ratio
- PMID: 17303661
- DOI: 10.1210/en.2006-1287
Synergistic expression of angiotensin-converting enzyme (ACE) and ACE2 in human renal tissue and confounding effects of hypertension on the ACE to ACE2 ratio
Abstract
Angiotensin-converting enzyme (ACE) 2, a newly emerging component of the renin-angiotensin system, is presumed to be a counterregulator against ACE in generating and degrading angiotensin II. It remains to be elucidated how mRNA levels of these two genes are quantitatively regulated in the kidney and also what kind of clinicopathological characteristics could influence the gene expressions in humans. Seventy-eight cases of biopsy-proven renal conditions were examined in detail. Total RNA from a small part of each renal cortical biopsy specimen was reverse transcribed, and the resultant cDNA was amplified for ACE, ACE2, and glyceraldehyde-3-phosphate dehydrogenase with a real-time PCR system. Then we investigated the relationship between clinicopathological variables and mRNA levels adjusted for glyceraldehyde-3-phosphate dehydrogenase. Statistically significant correlation was not observed between any clinicopathological variables and either of the gene expressions by pairwise comparison. However, a strong correlation was observed between the gene expressions of ACE and those of ACE2. Moreover, the ACE to ACE2 ratio was significantly higher in subjects with hypertension (HT) than that in subjects without HT. Whereas parameters of renal function, e.g. urinary protein excretion (UPE) and creatinine clearance (Ccr), are not significantly related to the ACE to ACE2 ratio as a whole, the HT status may reflect disease-induced deterioration of renal function. That is, UPE and Ccr of subjects with HT are significantly different from those without HT, in which a significant correlation is also observed between UPE and Ccr. Finally, stepwise regression analysis further revealed that only the HT status is an independent confounding determinant of the ACE to ACE2 ratio among the variables tested. Our data suggest that ACE2 might play an important role in maintaining a balanced status of local renin-angiotensin system synergistically with ACE by counterregulatory effects confounded by the presence of hypertension. Thus, ACE2 may exert pivotal effects on cardiovascular and renal conditions.
Similar articles
-
Relationship between renal injury and the antagonistic roles of angiotensin-converting enzyme (ACE) and ACE2.Genet Mol Res. 2014 Apr 3;13(2):2333-42. doi: 10.4238/2014.April.3.5. Genet Mol Res. 2014. PMID: 24781988
-
Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition.Exp Physiol. 2012 Apr;97(4):477-85. doi: 10.1113/expphysiol.2011.063156. Epub 2011 Dec 23. Exp Physiol. 2012. PMID: 22198016
-
Role of angiotensin-converting enzyme (ACE and ACE2) imbalance on tourniquet-induced remote kidney injury in a mouse hindlimb ischemia-reperfusion model.Peptides. 2012 Jul;36(1):60-70. doi: 10.1016/j.peptides.2012.04.024. Epub 2012 May 8. Peptides. 2012. PMID: 22580272
-
Emerging markers in cardiovascular disease: where does angiotensin-converting enzyme 2 fit in?Clin Exp Pharmacol Physiol. 2013 Aug;40(8):551-9. doi: 10.1111/1440-1681.12069. Clin Exp Pharmacol Physiol. 2013. PMID: 23432153 Review.
-
Angiotensin-converting enzyme 2: implications for blood pressure and kidney disease.Curr Opin Nephrol Hypertens. 2009 Jan;18(1):79-84. doi: 10.1097/MNH.0b013e32831b70ad. Curr Opin Nephrol Hypertens. 2009. PMID: 19077694 Review.
Cited by
-
Angiotensin-converting enzyme 2: the first decade.Int J Hypertens. 2012;2012:307315. doi: 10.1155/2012/307315. Epub 2011 Nov 10. Int J Hypertens. 2012. PMID: 22121476 Free PMC article.
-
Renin angiotensin system molecules and chemokine (C-C motif) ligand 2 (CCL2) in chronic kidney disease patients.J Bras Nefrol. 2022 Jan-Mar;44(1):19-25. doi: 10.1590/2175-8239-JBN-2021-0030. J Bras Nefrol. 2022. PMID: 34251390 Free PMC article.
-
Sex-related differences in COVID-19 lethality.Br J Pharmacol. 2020 Oct;177(19):4375-4385. doi: 10.1111/bph.15207. Epub 2020 Aug 5. Br J Pharmacol. 2020. PMID: 32698249 Free PMC article. Review.
-
Angiotensin-converting enzymes and drug discovery in cardiovascular diseases.Drug Discov Today. 2010 May;15(9-10):332-41. doi: 10.1016/j.drudis.2010.02.003. Epub 2010 Feb 17. Drug Discov Today. 2010. PMID: 20170743 Free PMC article. Review.
-
ACEIs, ARBs, ibuprofen originally linked to COVID-19: the other side of the mirror.Inflammopharmacology. 2020 Dec;28(6):1477-1480. doi: 10.1007/s10787-020-00755-x. Epub 2020 Sep 12. Inflammopharmacology. 2020. PMID: 32920716 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous